Provided By GlobeNewswire
Last update: May 21, 2024
JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5th, 2024.
NASDAQ:DRTS (5/30/2025, 4:30:01 PM)
2.985
-0.02 (-0.5%)
NASDAQ:DRTSW (5/30/2025, 4:00:39 PM)
0.21
-0.04 (-16%)
Find more stocks in the Stock Screener